The Sickle Cell Program conducts state-of-the-art clinical and laboratory research aimed at gaining a better understanding of the disease, preventing its complications and ultimately finding a cure. The center’s research funding is provided by government grants and the philanthropic support of a variety of community-based organizations.
Renowned for our research and therapies for blood disorders, physicians from the Sickle Cell Program at Texas Children's Hospital conduct state-of-the-art clinical and scientific research aimed at understanding, preventing and curing sickle cell disease. Texas Children's Hematology Center is dedicated to the integration of laboratory and clinical research to increase our understanding of blood disorders, and to develop new, more effective therapies for children who suffer from hematologic malignancies. The center receives funding through government grants and philanthropic efforts of a variety of community-based organizations.
Children receiving care at Texas Children’s have the opportunity to participate in several National Institutes of Health (NIH)-funded research studies led by physician scientists, providing the latest treatments for this disease. This partnership allows us to offer even more novel therapies to our sickle cell patients.
Texas Children's Hematology Center has been serving children with sickle cell disease since 1958. The service first employed a comprehensive program for screening newborns at the large Harris County Hospital District facility in 1975 and was instrumental in the creation of the State newborn screening program. Patients from 20 surrounding counties and East Texas are drawn to the program. However, for many years the growing numbers of patients made it clear that a separate infrastructure was necessary to support clinical care and research. In early 2001, the Texas Children’s Sickle Cell Center was formed to provide comprehensive care to the patients being followed by the service.